Training bioengineers to improve heart and lung health
Training in Bioengineering Research and Technology Development in Cardiovascular in Cardiopulmonary Health and Disease
This program is helping students learn how to create new tools and treatments for heart and lung diseases by combining different areas of science, so they can improve health for people like you.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10853136 on NIH RePORTER |
What this research studies
This program trains predoctoral students in bioengineering to develop innovative technologies for diagnosing and treating cardiovascular and cardiopulmonary diseases. Students will engage in interdisciplinary research that combines biomechanics, biomaterials, computational biology, and imaging techniques. The training includes coursework and mentorship from experts in various biomedical fields, focusing on both basic and translational research. The goal is to cultivate a new generation of bioengineers who can contribute to advancements in cardiovascular health.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with cardiovascular or cardiopulmonary conditions seeking innovative treatment options.
Not a fit: Patients with unrelated health issues or those not affected by cardiovascular or cardiopulmonary diseases may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking technologies that enhance the diagnosis and treatment of heart and lung diseases.
How similar studies have performed: Previous research in bioengineering has shown promise in developing technologies for cardiovascular health, indicating a strong potential for success in this area.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Mcculloch, Andrew D. — University of California, San Diego
- Study coordinator: Mcculloch, Andrew D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.